Dr. Liberman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Atwell Road
Cooperstown, NY 13326
Summary
- Dr. Amanda Liberman is a Resident Physician in Cooperstown, NY, who completed her medical education at Yale School of Medicine '24. She is undergoing residency in Public Health and General Preventive Medicine at Johns Hopkins Bloomberg School of Public Health (2025-2027) after a Transitional Year internship at Bassett Medical Center (2024-2025). Her research contributions include multiple publications in reputable journals, with her work focusing on methadone utilization. Dr. Liberman has been recognized with the MSD/IAS Prize for Research in Long-Acting HIV Prevention and Treatment by the International AIDS Society in 2023.
Education & Training
Johns Hopkins Bloomberg School of Public HealthResidency, Public Health and General Preventive Medicine, 2025 - 2027
Bassett Medical CenterInternship, Transitional Year, 2024 - 2025
Yale School of MedicineClass of 2024
Awards, Honors, & Recognition
- MSD/IAS Prize for Research in Long-Acting HIV Prevention and Treatment International AIDS Society (IAS), 2023
- 1819 Award Colgate University, 2013
Publications & Presentations
PubMed
- Exploration of the multi-level barriers to scaling up methadone for HIV prevention among people who inject drugs in Kazakhstan.Amanda R Liberman, Yelena Rozental, Roman Ivasiy, Ainur Zh Kussainova, Sholpan Primbetova
Journal of Substance Use and Addiction Treatment. 2025-02-20 - 5 citationsThe Properties and Domain Requirements for Phase Separation of the Sup35 Prion Protein In Vivo.Bryan Grimes, Walter Jacob, Amanda R Liberman, Nathan Kim, Xiaohong Zhao
Biomolecules. 2023-09-10 - Aligning public health and public safety: Probation as a touchpoint to identify and link patients with opioid use disorder to opioid agonist treatment.Daniel J Bromberg, Samy J Galvez de Leon, Taylor Litz, Lyu Azbel, Amanda R Liberman
PLOS Global Public Health. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
